Editorial Type:
Article Category: Research Article
 | 
Online Publication Date: 12 Feb 2025

Investigation of MMP1 rs1799750 and TGF1 rs1800470 polymorphisms in individuals with different vertical facial patterns and temporomandibular joint disorder

,
,
, and
Page Range: 317 – 322
DOI: 10.2319/070324-528.1
Save
Download PDF

ABSTRACT

Objectives

To evaluate the effects of rs1799750 1G/2G polymorphism of the MMP1 gene and rs1800470 T/C polymorphism of the TGF1 gene on temporomandibular disk displacement and vertical facial development.

Materials and Methods

Sixty-six individuals were examined radiographically prior to evaluation of the signs/symptoms of temporomandibular disorders according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). Class II, hyperdivergent individuals with TMD (+) were assigned to Group 1, and individuals with TMD (−) were included in Group 2; while Class I, normodivergent individuals with TMD (−) were included in Group 3. For genetic analysis, oral mucosa swab samples were collected, and genotype analysis was performed.

Results

The incidence of 2G alleles in Group 2 (72.7%) was significantly higher than the other groups (P < .05). ANB angle and mean Wits of the 1G/1G genotype of the MMP1 gene were significantly lower than 1G/2G and 2G/2G. Mean Go-Gn of the 1G/1G genotype was significantly higher than that of 1G/2G. The mean SNB of the TGF-β1 TT genotype was significantly higher than TC. The mean Co-Gn of TT was significantly higher than CC.

Conclusions

A relationship was found between the 2G allele of rs1799750 1G/2G polymorphisms of the MMP1 gene and the risk of individuals developing disk displacement. Also, it was found that TGF1 gene rs1800470 29 T/C polymorphisms had a detrimental effect on mandibular development.

INTRODUCTION

Temporomandibular joint disorder (TMD) is a complicated and multifactorial condition, typically characterized by joint dysfunction, joint and muscle pain, joint noise, mandibular hypomobility, and deviation of the mandible during mouth opening.1 The temporomandibular joint (TMJ) consists of a complex structure of extracellular matrix (ECM) molecules. Collagens, which are found in the fibrocartilage of the articular surface of the temporal bone and mandibular condyle, are involved in the function of the articular disk, maintain the form of tissues, and make them resistant to tensile forces. Both enzymatic and nonenzymatic mechanisms are responsible for the degradation of the ECM of the TMJ.2

Other than those caused by environmental variables, genetic differences may potentially play a role in the development of TMD.3 Individuals differ in their capacity to endure the same contributing risk factors, such as abnormal mechanical loading, aging, and gender impacts. Also, they may have varying degrees of sensitivity to TMD and different adaptive remodeling capacity during the degenerative phase, leading to various clinical outcomes.4 Under the same conditions, individuals that are susceptible to TMD are more sensitive to maladaptive molecular responses mediated by proinflammatory cytokines, neuropeptides, free radicals, and matrix-degrading enzymes.5

The TMJ articular disk is primarily composed of proteoglycan aggregates and collagen fibers, the majority of which are types 1 and 2 collagen. Physiologic maintenance of the disk is achieved through a balance between collagen fiber degradation performed by matrix metalloproteinases (MMP) and their inhibitors.6 Accelerated collagen breakdown has been linked to increased synthesis and overexpression of MMP1 in the synovial fluid of the TMJ of osteoarthritic patients.7,8 Previous researchers have demonstrated that the MMP1 gene 1G/2G polymorphism enhanced local MMP1 concentration, which contributed to quicker ECM degradation.9,10 Patients with the MMP1 rs1799750 polymorphism may show variable concentrations of MMP1, leading to higher collagen degradation and potentially increasing the risk of developing disk displacement (DD). Therefore, the primary aim of the present study was to evaluate the association between the 1607 1G/2G polymorphism of the MMP1 gene and DD and skeletal development.

TGF-β (transforming growth factor-β) regulates chondrocyte proliferation and differentiation as well as the formation and breakdown of the ECM.11 TGF-ß1 signaling appears to be important in the development of the orofacial area by regulating palate development in both the epithelium and the mesenchyme.12 Detamore and Athanasiou13 performed an in vitro study to evaluate TGF-β in pig TMJ cultures and discovered that TGF-β considerably controlled the formation of ECM components such as collagen and glycosaminoglycan. Patients with different TGF1 genotypes may show different concentrations of TGF1, leading to a growth-arresting effect and potentially increasing the likelihood of developing Class II skeletal relationships. Therefore, in the present study, we also aimed to evaluate the association between the T → C polymorphism of the TGF1 gene and DD and skeletal development.

MATERIALS AND METHODS

The prospective study protocol was approved by Marmara University, Faculty of Medicine, Clinical Research Ethics Committee (09.2022.280, 11/02/2022, Istanbul, Turkey). The study sample consisted of 66 individuals, 15 males and 51 females (15–40 years). Informed consent was obtained from all patients included in the study. The sample size was determined using G-Power 3.1.9.4 (Heinrich-Heine-University, Düsseldorf, Germany) software based on a previous study.14 A minimum of 22 participants was required for each group. Group 1 consisted of Class II hyperdivergent patients with TMD, Group 2 consisted of Class II hyperdivergent patients without TMD (ANB >4°, Go-MeSn >39°), and Group 3 consisted of Class I normodivergent patients without TMD (ANB <4°, Go-MeSn <39°; Table 1). Patients with previous orthodontic treatment or orthognathic surgery, cleft lip and palate, craniofacial syndromes, osteoarthritis of the TMJ, and rheumatic diseases were excluded from the study.

Table 1.Distribution of Age and Gender
Table 1.

Cephalometric radiographs obtained from the patients prior to orthodontic treatment were traced with NemoStudio NX-Pro 10.4.2 (Software Nemotec, Madrid, Spain) by the same researcher (B.T.). After cephalometric examination, patients were clinically evaluated by an experienced orthodontist based on the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD).15 Magnetic resonance imaging (MRI) was obtained for individuals in Group 1. During MRI examination, anterior DD without osteoarthritis was observed in at least one condyle of the patients as a finding.

Extraction and Analysis of Genomic Deoxyribonucleic Acid (gDNA)

Intraoral epithelial cells were collected with the help of DNA collection swabs. Then the DNA isolation process was completed using PureLink DNA isolation kit (Invitrogen, Van Allen Way Carlsbad, Calif). The DNA samples were kept at −20°C until the relevant gene area analysis was finished.

Taqman SNP genotyping kits (cat. no. 4371355, Thermo Fisher Scientific Inc., Waltham, MA, USA) and Real-Time PCR on StepOnePlus (Thermo Fisher Scientific Inc.) were used for genotyping assays. Genotyping was performed according to the manufacturer’s protocols.

Statistical Analysis

IBM SPSS Statistics version 22 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. Genotype and allele frequency distributions between Class II hyperdivergent patients with TMD and control groups were analyzed by χ2 test.

Conformity of the parameters to a normal distribution was evaluated by Shapiro-Wilk tests. One-way analysis of variance was used to compare parameters between treatment groups and between gene alleles, and Tukey HSD was used to determine the group causing the difference. Significance was evaluated at P < .05.

RESULTS

MMP1 Polymorphism

A statistically significant difference was found among the groups for distribution of MMP1 alleles (P = .017). The rate of the 2G allele in Group 2 (72.7%) was significantly higher than in Group 1 (47.7%) and Group 3 (25.5%; P < .05; Table 2).

Table 2.Evaluation of TGF-β1 and MMP1 Polymorphisms Among Groups
No. (%)
Group 1 Group 2 Group 3 P Value
TGF-β1
 TT 3 (13.6%) 8 (36.4%) 9 (40.9%) .113
 TC 11 (50%) 5 (22.7%) 4 (18.2%)
 CC 8 (36.4%) 9 (40.9%) 9 (40.9%)
TGF-β1 (allele)
 T 17 (38.6%) 21 (47.7%) 22 (50%) .526
 C 27 (61.4%) 23 (52.3%) 22 (50%)
MMP1
 1G/1G 6 (27.3%) 2 (9.1%) 9 (40.9%) .058
 1G/2G 11 (50%) 8 (36.4%) 6 (27.3%)
 2G/2G 5 (22.7%) 12 (54.5%) 7 (31.8%)
MMP1 (allele)
 1G 23 (52.3%) 12 (27.3%) 24 (54.5%) .017a
 2G 21 (47.7%) 32 (72.7%) 20 (25.5%)
 Chi-square test, P < .05.

Statistically significant differences were found between MMP1 subgroups (1G/1G, 1G/2G, and 2G/2G) for mean ANB angle and Wits value (P = .036 and .010, respectively). The means of the ANB angle and Wits value for the 1G/1G genotype were significantly lower than for 1G/2G and 2G/2G (P < .05; Table 3).

Table 3.Evaluation of MMP1 Polymorphisms Among Subgroups
Table 3.

A statistically significant difference between MMP1 subgroups was also found for mean Go-Gn (P = .030). The mean Go-Gn of 1G/1G was significantly greater than for 1G/2G (P < .05; Table 3).

TGF1 Polymorphism

Statistically significant differences were found between TGF1 subgroups (TT, TC, and CC) in SNB and GoMe-SN angles (P = .030 and .041, respectively). While mean SNB of the TT genotype was higher than TC, the mean GoMe-SN of TT was lower than in the TC genotype (P < .05; Table 4).

Table 4.Evaluation of TGF-β1 Polymorphisms Among Subgroups
Table 4.

A statistically significant difference between the TGF1 subgroups was also found for mean facial axis angle (P = .027). The mean facial axis angle of the TC genotype was significantly lower than for CC (P < .05; Table 4).

Also, a statistically significant difference was found between TGF1 subgroups in mean Co-Gn distance (P = .030), which showed significantly higher values in the TT genotype than in CC (P < .05; Table 4).

DISCUSSION

TMDs are very common in society. Their prevalence and frequency in different populations, symptoms, and etiology have been the subject of studies.16,17

Genetic variants may contribute to the development of TMD and the pain experience. Authors of several studies have linked genetic polymorphisms to musculoskeletal conditions such as fibromyalgia18 and lower back pain.19 This strongly suggests that TMD pathophysiology may also be significantly influenced by genetic conditions.

Authors of most studies have reported that a Class II skeletal relationship and hyperdivergent growth pattern are conditions associated with a higher risk for the development of TMD.20–22 Skeletal patterns associated with TMD include short ramus height and mandibular length, steep mandibular plane angle, increased profile convexity, and mandibular retrognathism.23

In this study, two of the groups had a Class II hyperdivergent skeletal pattern (Group 1 was TMD [+], and Group 2 was TMD [−]). Since these two groups both had a Class II skeletal relationship with hyperdivergent vertical pattern, skeletal relationship and vertical pattern alone, as a cause of joint disease, could be excluded. Additionally, the third group had a Class I skeletal relationship and normodivergent pattern without TMD. Group 3 was included in the present study to investigate the relationship between gene polymorphisms and skeletal relationships.

MMP1 Gene Polymorphism

In the present study, a statistically significant difference was found among the three groups in terms of allelic frequency of MMP1 rs1799750 polymorphism. The rate of the 2G allele was higher in Group 2 than the other groups. Other researchers found a higher rate of the 2G allele in individuals with TMD in their studies.14,24,25 In the current study, the heterozygous genotype 1G/2G was more common in Group 1, which agreed with Rosales et al.14 and Luo et al.25 Differences among the studies may have been due to inadequacies in TMD diagnosis. In the current study, patients were diagnosed based on clinical examination, panoramic radiography, and RDC/TMD due to ethical reasons. In some previous studies, advanced imaging techniques such as MRI and computed tomography images were used.

Many hypotheses have been formed regarding the causes of TMD. However, the multifactorial etiologic approach proposed by De Boever26 remains valid today due to the lack of scientific resources to support alternate hypotheses, which may have created differences between the study groups in the present study.

In the current study, although it was not statistically significant, 27.3% of Group 1 had the 1G/1G genotype, 9.1% of Group 2, and 40.9% of Group 3. Since Group 3 had Class I individuals with normal vertical dimensions, the homozygous 1G/1G genotype may be more common in individuals with normal skeletal development and a healthy TMJ.

A significant difference was found between MMP1 genotype subgroups for ANB angle and Wits value averages in the present study. The mean ANB angle and Wits value of 1G/1G were significantly lower than for 1G/2G and 2G/2G. These values provide information about the direction of skeletal development in individuals, and high values indicate the presence of a Class II skeletal relationship. The fact that these values were low in individuals with 1G/1G homozygous genotype suggests that MMP1 may provide information about skeletal development. The MMP1 1G/1G homozygous genotype increases the development of a skeletal Class I relationship.

Additionally, the Go-Gn distance of 1G/1G was significantly greater than for 1G/2G. Looking at the Go-Gn linear value, which provides information about mandibular corpus length, it could be speculated that the mandibular corpus length is longer in individuals with a homozygous 1G/1G genotype than in individuals with a heterozygous 1G/2G genotype.

This present study is the first one to examine MMP1 polymorphism and TMD in a small sample of the Turkish population. Additionally, we were the first to classify patients according to cephalometric values and to examine MMP1 polymorphism. In the future, further studies on this subject with larger sample sizes and using more accurate diagnostic tools or TMD will contribute more to the finalization of the results and the elucidation of this topic in the literature.

TGF1 Polymorphism

In the present study, heterozygous TC and homozygous CC individuals were more common in Group 1 than in the other groups, although the difference was not statistically significant. In the literature, Jiao et al.27 suggested that TGF1 may be an important marker for the development of TMJ osteoarthritis. No authors in the literature have investigated the relationship between TGF1 rs1800470 polymorphism and joint disorders. However, the presence of the C allele has been reported to cause diseases such as osteoarthritis, hip dysplasia, and rheumatoid arthritis.28,29 Therefore, the greater percentage of the C allele in Group 1, which had TMD patients, may support these findings.

In the TGF1 genotype subgroups, some of the skeletal values showed significant differences. While the SNB angle in the TT subgroup was greater than in TC, the Co-Gn distance was greater in the TT subgroup than in CC. Since these values are both related to mandibular growth, it may be concluded that the presence of the C allele negatively affects mandibular growth.

Additionally, while GoMe-SN in the TC subgroup was significantly higher than TT, the facial axis angle was significantly lower in TC. Although the other differences were not statistically significant, it can be speculated that higher ratios of vertical height were seen in the heterozygous TC subgroup.

In the literature, this article is the first one relating TGF1 rs1800470 polymorphism and craniofacial development. Although the results were not statistically significant, it might be suggested that the presence of the C allele negatively affects mandibular growth. To reach statistically significant results, increasing the sample size and looking at these linear and angular values may contribute to the literature on mandibular development. In the future, having more information about genetic skeletal deformities in individuals may provide further information to guide growth during treatment.

CONCLUSIONS

  • In the present study, the 1G/2G genotype, which is the heterozygous genotype in MMP1 rs1799750 polymorphism, may be a risk factor for the development of TMD, and the 1G/1G genotype is thought to be a genotype that protects individuals from TMD.

  • The TGF1 TC heterozygous genotype was found more frequently in Group 1 individuals with TMD than in healthy individuals. The TC genotype, which is the heterozygous genotype in the TGF-ß1 rs1800470 polymorphism, may be a risk factor for the development of TMD.

  • Patients with the 1G/1G genotype were more prone to having a Class I skeletal relationship. The presence of 2G in MMP1 rs1799750 polymorphism is thought to negatively affect mandibular growth.

  • Finally, the TGF1 rs1800470 29 T/C polymorphisms may have a detrimental effect on mandibular development, and heterozygous TC genotype may increase vertical growth in individuals.

ACKNOWLEDGMENTS

This study was funded by Marmara University, Scientific Research Projects Department (Project code TDH-2022-10523). It was presented at 18th International Turkish Orthodontic Society Symposium and received first prize in oral presentations.

REFERENCES

  • 1.
    Liu F, Steinkeler A. Epidemiology, diagnosis, and treatment of temporomandibular disorders. Dent Clin North Am. 2013;57(
    3
    ):465479.
  • 2.
    Fonseca R. Oral and Maxillofacial Surgery.
    Philadelphia, PA
    :
    WB Saunders Company
    ; 2000:220271.
  • 3.
    Meloto CB, Serrano PO, Ribeiro-DaSilva MC, Rizzatti-Barbosa CM. Genomics and the new perspectives for temporomandibular disorders. Arch Oral Biol. 2011;56(
    11
    ):11811191.
  • 4.
    Tanaka E, Detamore M, Mercuri L. Degenerative disorders of the temporomandibular joint: etiology, diagnosis, and treatment. J Dent Res. 2008;87(
    4
    ):296307.
  • 5.
    Milam SB. Pathogenesis of degenerative temporomandibular joint arthritides. Odontology. 2005;93(
    1
    ):715.
  • 6.
    Perotto JH, Camejo FA, Doetzer AD, et al. Expression of MMP-13 in human temporomandibular joint disc derangement and osteoarthritis. Cranio. 2018;36(
    3
    ):161166.
  • 7.
    Srinivas R, Sorsa T, Tjäderhane L, et al. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(
    5
    ):517525.
  • 8.
    Ferreira LM, Moura ÁF, Barbosa GA, Pereira HS, Dos Santos Calderon P. Do matrix metalloproteinases play a role in degenerative disease of temporomandibular joint? A systematic review. Cranio. 2016;34(
    2
    ):112117.
  • 9.
    Arakaki PA, Marques MR, Santos MC. MMP-1 polymorphism and its relationship to pathological processes. J Biosci. 2009;34(
    2
    ):313320.
  • 10.
    Rutter JL, Mitchell TI, Butticè G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998;58(
    23
    ):53215325.
  • 11.
    Blaney Davidson EN, van der Kraan PM, van den Berg WB. TGF-beta and osteoarthritis. Osteoarthritis Cartilage. 2007;15(
    6
    ):597604.
  • 12.
    Iwata J, Parada C, Chai Y. The mechanism of TGF-β signaling during palate development. Oral Dis. 2011;17(
    8
    ):733744.
  • 13.
    Detamore MS, Athanasiou KA. Evaluation of three growth factors for TMJ disc tissue engineering. Ann Biomed Eng. 2005;33(
    3
    ):383390.
  • 14.
    Rosales AS, Rodríguez EAV, González CLL, Arellano EDR, Rubio SAG, Cobián TAG. Association between −1607 1G/2G polymorphism of MMP1 and temporomandibular joint anterior disc displacement with reduction. Braz Dent J. 2020;31(
    2
    ):152156.
  • 15.
    Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28(
    1
    ):627.
  • 16.
    Costa AL, D’Abreu A, Cendes F. Temporomandibular joint internal derangement: association with headache, joint effusion, bruxism, and joint pain. J Contemp Dent Pract. 2008;9(
    6
    ):916.
  • 17.
    Dworkin SF, Huggins KH, LeResche L, et al. Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls. J Am Dent Assoc. 1990;120(
    3
    ):273281.
  • 18.
    Matsuda JB, Barbosa FR, Morel LJ, et al. Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? Rev Bras Reumatol. 2010;50(
    2
    ):141149.
  • 19.
    Mishra BK, Wu T, Belfer I, et al. Do motor control genes contribute to interindividual variability in decreased movement in patients with pain? Mol Pain. 2007;3:20.
  • 20.
    Byun ES, Ahn SJ, Kim TW. Relationship between internal derangement of the temporomandibular joint and dentofacial morphology in women with anterior open bite. Am J Orthod Dentofacial Orthop. 2005;128(
    1
    ):8795.
  • 21.
    Bertram S, Moriggl A, Neunteufel N, Rudisch A, Emshoff R. Lateral cephalometric analysis of mandibular morphology: discrimination among subjects with and without temporomandibular joint disk displacement and osteoarthrosis. J Oral Rehabil. 2012;39(
    2
    ):9399.
  • 22.
    Jung WS, Kim H, Jeon DM, Mah SJ, Ahn SJ. Magnetic resonance imaging-verified temporomandibular joint disk displacement in relation to sagittal and vertical jaw deformities. Int J Oral Maxillofac Surg. 2013;42(
    9
    ):11081115.
  • 23.
    Sun ZP, Zou BS, Zhao YP, Ma XC. Craniofacial morphology of Chinese patients with bilateral temporomandibular joint osteoarthrosis. Chin J Dent Res. 2011;14(
    1
    ):2127.
  • 24.
    Planello AC, Campos MI, Meloto CB, et al. Association of matrix metalloproteinase gene polymorphism with temporomandibular joint degeneration. Eur J Oral Sci. 2011;119(
    1
    ):16.
  • 25.
    Luo S, Deng M, Long X, Li J, Xu L, Fang W. Association between polymorphism of MMP-1 promoter and the susceptibility to anterior disc displacement and temporomandibular joint osteoarthritis. Arch Oral Biol. 2015;60(
    11
    ):16751680.
  • 26.
    De Boever JA. Functional disturbances of the temporomandibular joints. Oral Sci Rev. 1973;2:100117.
  • 27.
    Jiao K, Zhang M, Niu L, et al. Overexpressed TGF-β in subchondral bone leads to mandibular condyle degradation. J Dent Res. 2014;93(
    2
    ):140147.
  • 28.
    Kolundžić R, Trkulja V, Mikolaučić M, Kolundžić MJ, Pavelić SK, Pavelić K. Association of interleukin-6 and transforming growth factor-β1 gene polymorphisms with developmental hip dysplasia and severe adult hip osteoarthritis: a preliminary study. Cytokine. 2011;54(
    2
    ):125128.
  • 29.
    Iriyoda TMV, Flauzino T, Costa NT, Lozovoy MAB, Reiche EMV, Simão ANC. TGFB1 (rs1800470 and rs1800469) variants are independently associated with disease activity and autoantibodies in rheumatoid arthritis patients. Clin Exp Med. 2022;22(
    1
    ):3745.
Copyright: © 2025 by The EH Angle Education and Research Foundation, Inc.

Contributor Notes

 Assistant Professor, Department of Orthodontics, Faculty of Dentistry, Marmara University, Istanbul, Turkey.
 Associate Professor, Department of Orthodontics, Faculty of Dentistry, Marmara University, Istanbul, Turkey.
 Assistant Professor, Department of Basic Medical Sciences, Division of Medical Biology and Genetics, Faculty of Dentistry, Marmara University, Istanbul, Turkey.
 MSc Student, Department of Basic Medical Sciences, Institute of Health Sciences, Marmara University, Istanbul, Turkey.
Corresponding author: Dr Begum Turan, Marmara Universitesi Basibuyuk Saglik Yerleskesi, Dis Hekimligi Fakultesi, Ortodonti Anabilim Dali, Maltepe 9/34854, Istanbul, Turkey (e-mail: begumturanbt@gmail.com)
Received: 03 Jul 2024
Accepted: 07 Jan 2025
  • Download PDF